Literature DB >> 23525850

Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.

Theru A Sivakumaran1, Ammar Husami, Diane Kissell, Wenying Zhang, Mehdi Keddache, Angela P Black, Brad T Tinkle, John H Greinwald, Kejian Zhang.   

Abstract

OBJECTIVE: To evaluate the performance of a next-generation sequencing (NGS)-based targeted resequencing genetic test, OtoSeq, to identify the sequence variants in the genes causing sensorineural hearing loss (SNHL). STUDY
DESIGN: Retrospective study.
SETTING: Tertiary children's hospital. SUBJECTS AND METHODS: A total of 8 individuals presenting with prelingual hearing loss were used in this study. The coding and flanking intronic regions of 24 well-studied SNHL genes were enriched using microdroplet polymerase chain reaction and sequenced on an Illumina HiSeq 2000 sequencer. The filtered high-quality sequence reads were mapped to reference sequence, and variants were detected using NextGENe software.
RESULTS: A total of 1148 sequence variants were detected in 8 samples in 24 genes. Using in-house developed NGS data analysis criteria, we classified 810 (~71%) of these variants as potential true variants that include previously detected pathogenic mutations in 5 patients. To validate our strategy, we Sanger sequenced the target regions of 5 of the 24 genes, accounting for about 29.2% of all target sequence. Our results showed >99.99% concordance between NGS and Sanger sequencing in these 5 genes, resulting in an analytical sensitivity and specificity of 100% and 99.997%, respectively. We were able to successfully detect single base substitutions, small deletions, and insertions of up to 22 nucleotides.
CONCLUSION: This study demonstrated that our NGS-based mutation screening strategy is highly sensitive and specific in detecting sequence variants in the SNHL genes. Therefore, we propose that this NGS-based targeted sequencing method would be an alternative to current technologies for identifying the multiple genetic causes of SNHL.

Entities:  

Keywords:  clinical diagnosis; genetic etiology; hearing loss; microdroplet PCR; mutation screening; next-generation sequencing

Mesh:

Year:  2013        PMID: 23525850     DOI: 10.1177/0194599813482294

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  14 in total

1.  The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.

Authors:  Sonata Jodele; Kejian Zhang; Fanggeng Zou; Benjamin Laskin; Christopher E Dandoy; Kasiani C Myers; Adam Lane; Jaroslav Meller; Mario Medvedovic; Jenny Chen; Stella M Davies
Journal:  Blood       Date:  2015-11-24       Impact factor: 22.113

2.  A novel mutation of EYA4 in a large Chinese family with autosomal dominant middle-frequency sensorineural hearing loss by targeted exome sequencing.

Authors:  Yi Sun; Zhao Zhang; Jing Cheng; Yu Lu; Chang-Liang Yang; Yan-Yun Luo; Guang Yang; Hui Yang; Li Zhu; Jia Zhou; Hang-Qi Yao
Journal:  J Hum Genet       Date:  2015-03-26       Impact factor: 3.172

Review 3.  Massively Parallel Sequencing for Genetic Diagnosis of Hearing Loss: The New Standard of Care.

Authors:  A Eliot Shearer; Richard J H Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2015-06-17       Impact factor: 3.497

4.  Genetic analysis through OtoSeq of Pakistani families segregating prelingual hearing loss.

Authors:  Mohsin Shahzad; Theru A Sivakumaran; Tanveer A Qaiser; Julie M Schultz; Zawar Hussain; Megan Flanagan; Munir A Bhinder; Diane Kissell; John H Greinwald; Shaheen N Khan; Thomas B Friedman; Kejian Zhang; Saima Riazuddin; Sheikh Riazuddin; Zubair M Ahmed
Journal:  Otolaryngol Head Neck Surg       Date:  2013-06-14       Impact factor: 3.497

5.  TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss.

Authors:  Hela Azaiez; Kevin T Booth; Fengxiao Bu; Patrick Huygen; Seiji B Shibata; A Eliot Shearer; Diana Kolbe; Nicole Meyer; E Ann Black-Ziegelbein; Richard J H Smith
Journal:  Hum Mutat       Date:  2014-05-06       Impact factor: 4.878

6.  Targeted Next-Generation Sequencing in Patients with Non-syndromic Congenital Heart Disease.

Authors:  Silvia Pulignani; Cecilia Vecoli; Andrea Borghini; Ilenia Foffa; Lamia Ait-Alì; Maria Grazia Andreassi
Journal:  Pediatr Cardiol       Date:  2018-01-13       Impact factor: 1.655

7.  Similar phenotypes caused by mutations in OTOG and OTOGL.

Authors:  Anne M M Oonk; Joop M Leijendeckers; Patrick L M Huygen; Margit Schraders; Miguel del Campo; Ignacio del Castillo; Mustafa Tekin; Ilse Feenstra; Andy J Beynon; Henricus P M Kunst; Ad F M Snik; Hannie Kremer; Ronald J C Admiraal; Ronald J E Pennings
Journal:  Ear Hear       Date:  2014 May-Jun       Impact factor: 3.570

8.  High prevalence of CDH23 mutations in patients with congenital high-frequency sporadic or recessively inherited hearing loss.

Authors:  Kunio Mizutari; Hideki Mutai; Kazunori Namba; Yuko Miyanaga; Atsuko Nakano; Yukiko Arimoto; Sawako Masuda; Noriko Morimoto; Hirokazu Sakamoto; Kimitaka Kaga; Tatsuo Matsunaga
Journal:  Orphanet J Rare Dis       Date:  2015-05-13       Impact factor: 4.123

9.  Resolving the genetic heterogeneity of prelingual hearing loss within one family: Performance comparison and application of two targeted next generation sequencing approaches.

Authors:  Yu Lu; Xueya Zhou; Zhanguo Jin; Jing Cheng; Weidong Shen; Fei Ji; Liyang Liu; Xuegong Zhang; Michael Zhang; Ye Cao; Dongyi Han; KwongWai Choy; Huijun Yuan
Journal:  J Hum Genet       Date:  2014-09-18       Impact factor: 3.172

Review 10.  Genetics of hearing loss in Africans: use of next generation sequencing is the best way forward.

Authors:  Kamogelo Lebeko; Jason Bosch; Jean Jacques Nzeale Noubiap; Collet Dandara; Ambroise Wonkam
Journal:  Pan Afr Med J       Date:  2015-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.